Pages that link to "Q35825980"
Jump to navigation
Jump to search
The following pages link to Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria (Q35825980):
Displaying 50 items.
- Artemisinin combination therapy for vivax malaria (Q24622539) (← links)
- Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial (Q28469217) (← links)
- An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia (Q28474978) (← links)
- Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium vivax malaria in endemic countries: meta-analysis of randomized controlled studies (Q28535686) (← links)
- Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial (Q28542921) (← links)
- Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis. (Q31153944) (← links)
- Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison (Q33276757) (← links)
- Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria (Q33279066) (← links)
- Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria (Q33298467) (← links)
- Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda (Q33342827) (← links)
- Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis (Q33489551) (← links)
- Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation (Q33559111) (← links)
- Intermittent preventive treatment: efficacy and safety of sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine plus piperaquine regimens in schoolchildren of the Democratic Republic of Congo: a study protocol for a randomized controlled trial (Q33589334) (← links)
- Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling (Q33678483) (← links)
- Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina Faso (Q33826359) (← links)
- Effects of a high-fat meal on the relative oral bioavailability of piperaquine (Q33836733) (← links)
- Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria (Q33903438) (← links)
- Absorption‐dependent apparent volume of distribution at steady state (Vss/F) in pharmacokinetic data analysis (Q34015139) (← links)
- Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand (Q34116219) (← links)
- Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval (Q34298973) (← links)
- Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing (Q34299078) (← links)
- Effect of coadministered fat on the tolerability, safety, and pharmacokinetic properties of dihydroartemisinin-piperaquine in Papua New Guinean children with uncomplicated malaria. (Q34299178) (← links)
- Piperaquine: a resurgent antimalarial drug. (Q34378146) (← links)
- Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study (Q34503134) (← links)
- Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children (Q34562333) (← links)
- Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children (Q34662803) (← links)
- Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola (Q34922694) (← links)
- Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challenges (Q34953705) (← links)
- Development, evaluation, and application of an in silico model for antimalarial drug treatment and failure. (Q35065737) (← links)
- Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model (Q35107675) (← links)
- A small amount of fat does not affect piperaquine exposure in patients with malaria (Q35191426) (← links)
- Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area (Q35203883) (← links)
- Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination (Q35224221) (← links)
- Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria (Q35598379) (← links)
- Plasmodium vivax treatments: what are we looking for? (Q35760893) (← links)
- Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria (Q35806356) (← links)
- Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria (Q35825877) (← links)
- Retrospective population pharmacokinetics of levocetirizine in atopic children receiving cetirizine: the ETAC study (Q35827304) (← links)
- Randomized Noninferiority Trial of Dihydroartemisinin-Piperaquine Compared with Sulfadoxine-Pyrimethamine plus Amodiaquine for Seasonal Malaria Chemoprevention in Burkina Faso (Q35859844) (← links)
- Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria (Q35867343) (← links)
- Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study (Q38631440) (← links)
- Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria (Q36018642) (← links)
- Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness. (Q36075783) (← links)
- Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria (Q36080121) (← links)
- Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria (Q36088256) (← links)
- The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated Plasmodium falciparum malaria in south-central Vietnam (Q36138872) (← links)
- Antimalarial drugs: current status and new developments (Q36196479) (← links)
- Ultrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs (Q36240246) (← links)
- Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria. (Q36422652) (← links)
- Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model (Q36422706) (← links)